Doccheck AG logo

AJ91 - Doccheck AG Share Price

€25.8 -0.2  -0.8%

Last Trade - 24/02/21

Consumer Cyclicals
Small Cap
Market Cap £111.8m
Enterprise Value £99.9m
Revenue £32.8m
Position in Universe 692nd / 1045
Unlock AJ91 Revenue
Relative Strength (%)
1m +3.86%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
19.9 26.8 25.9 28.1 28.3 32.4 +10.2%
+78.7 +47.8 -4.0 -1.3 -13.1 +55.2
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, DocCheck AGrevenues increased 38% to EUR20.9M. Net income increased90% to EUR2.5M. Revenues reflect DocCheck, Commerce andLogistics segment increase of 84% to EUR7.3M, antwerpes +partner segment increase of 19% to EUR10.8M. Net incomebenefited from Interest Income increase of 14% to EUR121K(income), Income from investments increase of 8% to EUR7K(income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for AJ91
Graphical History


AJ91 Revenue Unlock AJ91 Revenue

Net Income

AJ91 Net Income Unlock AJ91 Revenue

Normalised EPS

AJ91 Normalised EPS Unlock AJ91 Revenue

PE Ratio Range

AJ91 PE Ratio Range Unlock AJ91 Revenue

Dividend Yield Range

AJ91 Dividend Yield Range Unlock AJ91 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AJ91 EPS Forecasts Unlock AJ91 Revenue
Profile Summary

DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since November 4, 2011
No. of Shareholders: n/a
No. of Employees: 282
Sector Consumer Cyclicals
Industry Media & Publishing
Exchange Frankfurt Stock Exchange
Shares in Issue 5,033,876
Free Float (0.0%)
Eligible for
AJ91 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AJ91
Upcoming Events for AJ91
Frequently Asked Questions for Doccheck AG
What is the Doccheck AG share price?

As of 24/02/21, shares in Doccheck AG are trading at €25.8, giving the company a market capitalisation of £111.8m. This share price information is delayed by 15 minutes.

How has the Doccheck AG share price performed this year?

Shares in Doccheck AG are currently trading at €25.8 and the price has moved by 0.174k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Doccheck AG price has moved by 0.171k% over the past year.

What are the analyst and broker recommendations for Doccheck AG?

Of the analysts with advisory recommendations for Doccheck AG, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Doccheck AG is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Doccheck AG next release its financial results?

Doccheck AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Doccheck AG dividend yield?

The Doccheck AG dividend yield is 0.38% based on the trailing twelve month period.

Does Doccheck AG pay a dividend?

Last year, Doccheck AG paid a total dividend of 0.1, and it currently has a trailing dividend yield of 0.38%. Looking ahead, Doccheck AG has not announced an ex-dividend date yet.

When does Doccheck AG next pay dividends?

Doccheck AG has yet to annouce their ex-dividend date. The historic dividend yield on Doccheck AG shares is currently 0.38%.

How do I buy Doccheck AG shares?

To buy shares in Doccheck AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Doccheck AG?

Shares in Doccheck AG are currently trading at €25.8, giving the company a market capitalisation of £111.8m.

Where are Doccheck AG shares listed? Where are Doccheck AG shares listed?

Here are the trading details for Doccheck AG:

Country of listing: Germany
Exchange: FRA
Ticker Symbol: AJ91
What kind of share is Doccheck AG?

Based on an overall assessment of its quality, value and momentum, Doccheck AG is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Doccheck AG share price forecast 2021?

We were not able to load any forecast data for Doccheck AG.

How can I tell whether the Doccheck AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Doccheck AG. Over the past six months, the relative strength of its shares against the market has been 63.39%. At the current price of €25.8, shares in Doccheck AG are trading at 53.4% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Doccheck AG PE Ratio?

The Doccheck AG PE ratio based on its reported earnings over the past 12 months is 29.81. The shares are currently trading at €25.8.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Doccheck AG?

Doccheck AG's management team is headed by:

Frank Antwerpes - CEO
Joachim Pietzko - CSU
Winfried Leimeister - SUB
Helmut Rieger - MGB
Britta Boeckmann - VSU
Michael Vorbrink - EXB
Thilo Koelzer - CEX
Who are the major shareholders of Doccheck AG?

Here are the top five shareholders of Doccheck AG based on the size of their shareholding:

Antwerpes (Frank) Individual Investor
Percentage owned: 55.44% (2.79m shares)
Antwerpes (Pia) Individual Investor
Percentage owned: 16.09% (810k shares)
Investmentaktiengesellschaft für Langfristige Investoren TGV Investment Advisor/Hedge Fund
Percentage owned: 7.76% (391k shares)
pfp Advisory GmbH Investment Advisor
Percentage owned: 1.45% (72.8k shares)
DWS Concept Platow Mutual Fund
Percentage owned: 1.45% (72.8k shares)
Similar to AJ91
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.